On September 6, 2022, the U.S. Food and Drug Administration cleared the way for marketing of a rapid-acting brain-stimulation approach for major depressive disorder pioneered by Nolan Williams, M.D…
Read More
The last decade has seen a vast increase in the use of brain stimulation technologies to reduce symptoms of psychiatric illness. By far the most influential has been TMS, a non-invasive method…
Read More
TMS (transcranial magnetic stimulation), a form of non-invasive brain stimulation used to treat depression, has shown its ability to reduce symptoms in many thousands of patients in the years since…
Read More
A research team led in part by two BBRF grantees has reported initial success in using a novel, highly personalized, and technologically advanced treatment approach to relieve symptoms in a single…
Read More
Researchers have reported that the brain circuitry underlying depression is the same or similar in a wide variety of patients and circumstances, and that it is similar to circuitry affected when…
Read More
